Brenda Schulman

Brenda Arlene Schulman is an American biochemist and structural biologist who is a Director at the Max Planck Institute of Biochemistry, Martinsried, Bavaria. Schulman's research interests focus on a class of proteins known as ubiquitin-like proteins.

Education and academic career Schulman is a native of Tucson, Arizona. Schulman received her bachelor's degree in biology from Johns Hopkins University in 1989 and her PhD in biology from the Massachusetts Institute of Technology in 1996, advised by Peter S. Kim. She then worked as a postdoctoral fellow with Ed Harlow at the Massachusetts General Hospital Cancer Center and later with Nikola Pavletich at the Memorial Sloan Kettering Cancer Center. After sixteen years at St. Jude's, Schulman moved to the Max Planck Institute in 2017.

Honors and awards 2014 Election to member of the National Academy of Sciences of the US 2019 Ernst Jung Prize for Medicine 2019 Gottfried Wilhelm Leibniz Prize 2019 Member of the German Academy of Sciences Leopoldina. 2023 Louis-Jeantet Prize for Medicine 2026 Elected Fellow of the Royal Society